Anti-Catenin, beta Antibody Clone 5H10
Additionally, this antibody has been validated by MS–QAVA™.
Search Results for: ms-qava
Anti-p21WAF1 Antibody Clone CIP1/823
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Bax Antibody Clone 2D2
![Analysis of Mass Spec data (dashed-line) of fractions stained with Bax MS-QAVA™ monoclonal antibody [Clone: 2D2] (solid-line), reveals that less than 10.4% of signal is attributable to non-specific binding of anti-Bax Anti-Human, Monkey [Clone 2D2] to targets other than BAX protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-581-MSM1-P1-anti-Bax-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Cytokeratin 8/18 Antibody Clone KRT8.18/1346
Additionally, this antibody has been validated by MS–QAVA™.
Anti-CD44 / HCAM Antibody Clone HCAM/918
![Analysis of Mass Spec data (dashed-line) of fractions stained with CD44 / HCAM MS-QAVA™ monoclonal antibody [Clone: HCAM/918] (solid-line), reveals that less than 12.6% of signal is attributable to non-specific binding of anti-CD44 / HCAM Std. Anti-Human, Primate [Clone HCAM/918] to targets other than CD44 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-960-MSM2-P1-anti-CD44-HCAM-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-MCM7 Antibody Clone MCM7/1468
![Analysis of Mass Spec data (dashed-line) of fractions stained with MCM7 MS-QAVA™ monoclonal antibody [Clone: MCM7/1468] (solid-line), reveals that less than 3.8% of signal is attributable to non-specific binding of anti-MCM7 [Clone: MCM7/1468] to targets other than MCM7 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-4176-MSM3-P0-anti-MCM7-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-p53 Tumor Suppressor Protein Antibody Clone BP53-12 + DO-7
![Analysis of Mass Spec data (dashed-line) of fractions stained with p53 Tumor Suppressor Protein MS-QAVA™ monoclonal antibody [Clone: BP53-12 + DO-7] (solid-line), reveals that less than 10.8% of signal is attributable to non-specific binding of anti-p53 Tumor Suppressor Protein [Clone BP53-12 + DO-7] to targets other than TP53 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-7157-MSM3-P1-anti-p53-Tumor-Suppressor-Protein-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Cdk1 / p34cdc2 Antibody Clone CDK1/873
![Analysis of Mass Spec data (dashed-line) of fractions stained with Cdk1 / p34cdc2 MS-QAVA™ monoclonal antibody [Clone: CDK1/873] (solid-line), reveals that less than 1.4% of signal is attributable to non-specific binding of anti-Cdk1 / p34cdc2 [Clone CDK1/873] to targets other than CDC2 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-983-MSM2-P1-anti-Cdk1-p34cdc2-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-ZAP70 Antibody Clone 2F3.2
![Analysis of Mass Spec data (dashed-line) of fractions stained with ZAP70 MS-QAVA™ monoclonal antibody [Clone: 2F3.2] (solid-line), reveals that less than 2.3% of signal is attributable to non-specific binding of anti-ZAP70 [Clone 2F3.2] to targets other than ZAP70 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-7535-MSM1-P1-anti-ZAP70-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-SUMO-1 Antibody Clone SUMO1/1188
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Cytokeratin 7 Antibody Clone KRT7/1499R
![Analysis of Mass Spec data (dashed-line) of fractions stained with Cytokeratin 7 MS-QAVA™ monoclonal antibody [Clone: KRT7/1499R] (solid-line), reveals that less than 13.6% of signal is attributable to non-specific binding of anti-Cytokeratin 7 [Clone KRT7/1499R] to targets other than KRT7 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-3855-RBM9-P0-anti-Cytokeratin-7-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Vimentin Antibody Clone VM1170
Additionally, this antibody has been validated by MS–QAVA™.
Anti-p21WAF1 Antibody Clone DCS-60.2
![Analysis of Mass Spec data (dashed-line) of fractions stained with p21WAF1 MS-QAVA™ monoclonal antibody [Clone: DCS-60.2] (solid-line), reveals that less than 14% of signal is attributable to non-specific binding of anti-p21WAF1 [Clone DCS-60.2] to targets other than CDKN1A protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-1026-MSM2-P1-anti-p21WAF1-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-p21WAF1 Antibody Clone WA-1
![Analysis of Mass Spec data (dashed-line) of fractions stained with p21WAF1 MS-QAVA™ monoclonal antibody [Clone: WA-1] (solid-line), reveals that less than 10.9% of signal is attributable to non-specific binding of anti-p21WAF1 [Clone WA-1] to targets other than CDKN1A protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-1026-MSM1-P1-anti-p21WAF1-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Cytokeratin 19 Antibody Clone A53-B/A2.26
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Cytokeratin 8/18 Antibody Clone C-43 + DC10
Additionally, this antibody has been validated by MS–QAVA™.
Anti-p21WAF1 Antibody Clone HJ21
![Analysis of Mass Spec data (dashed-line) of fractions stained with p21WAF1 MS-QAVA™ monoclonal antibody [Clone: HJ21] (solid-line), reveals that less than 11.3% of signal is attributable to non-specific binding of anti-p21WAF1 [Clone HJ21] to targets other than CDKN1A protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-1026-MSM4-P1-anti-p21WAF1-antibody.png)
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Moesin Antibody Clone MSN/492
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Cytokeratin 8 Antibody Clone H1
Additionally, this antibody has been validated by MS–QAVA™.
Anti-Cytokeratin 7 Antibody Clone OV-TL12/30
Additionally, this antibody has been validated by MS–QAVA™.